The study aims to identify the optimal dose of BI 1584862 and observe its impact on improving GA patients' eyes.

Trials of IFx-Hu2.0 are initiating, looking to overcome checkpoint inhibitor resistance in Merkel cell carcinoma.

Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...

About the TUPELO Trial Design (REC-4881) The Phase 1b/2 TUPELO trial is evaluating the safety, tolerability, pharmacokinetics ...

The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...

The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal ...

LONDON, GB / ACCESS Newswire / April 28, 2025 / The Progressive Supranuclear Palsy (PSP) Trial Platform (PTP ... In a 3-month Phase 2a study in PSP patients, AZP2006 demonstrated encouraging clinical ...

Inhibition of GSK-3β may inhibit tumor growth and improve survival through several complimentary mechanisms that include enhancement of chemotherapy activity, activation of innate anti-tumor immunity, ...

In a Phase 1b/2a trial for lymphoma and cytokine release syndrome, the first group's dose-limiting toxicity observation ...

Synhale has acquired telaglenastat, and is planning a Phase 2 clinical trial testing the therapy in patients with pulmonary ...

and reproducible results support drug development as well as translational and clinical biomarker research Today marks the global launch of ZEISS Axioscan 7 spatial biology. The newly optimized ...

The FDA has freed Amgen’s mysterious early-stage obesity asset from a clinical hold ... to share new data in June on the asset from a phase 2 trial recruiting adults with obesity or who are ...